Gemcitabine
Showing 26 - 50 of 3,247
Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)
Not yet recruiting
- Metastatic Triple-Negative Breast Cancer
- Trilaciclib
- +3 more
-
Charlotte, North CarolinaLevine Cancer Institute
Aug 31, 2023
Unresectable Intrahepatic Cholangiocarcinoma Trial (Camrelizumab, Gemcitabine Injection, Cisplatin injection)
Not yet recruiting
- Unresectable Intrahepatic Cholangiocarcinoma
- Camrelizumab
- +4 more
- (no location specified)
Feb 17, 2023
NSCLC Trial (Milciclib Dose: 150 mg/day Mode of administration: oral)
Not yet recruiting
- NSCLC
- Milciclib Dose: 150 mg/day Mode of administration: oral
- (no location specified)
Dec 12, 2022
Cholangiocarcinoma Non-resectable Trial in Chengdu (Candonilimab, Cisplatin, Gemcitabine)
Recruiting
- Cholangiocarcinoma Non-resectable
- Candonilimab
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Aug 4, 2023
Urinary Bladder Cancer Trial in Tucson (Gemcitabine)
Not yet recruiting
- Urinary Bladder Cancer
- Gemcitabine
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Dec 21, 2022
Nasopharyngeal Carcinoma Trial in Guangzhou (Camrelizumab, Gemcitabine, Cisplatin)
Recruiting
- Nasopharyngeal Carcinoma
- Camrelizumab
- +3 more
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 3, 2023
Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)
Not yet recruiting
- Metastatic Pancreatic Cancer
- Gemcitabine
- +3 more
-
Washington, District of ColumbiaLombardi Comprehensive Cancer Center, Georgetown University
Apr 11, 2023
Locally Advanced Pancreatic Cancer Trial in Shanghai (Tumor treating fields combined with Gemcitabine HCl and albumin binding
Not yet recruiting
- Locally Advanced Pancreatic Cancer
- Tumor treating fields combined with Gemcitabine hydrochloride and albumin binding paclitaxel
- Gemcitabine hydrochloride and albumin binding paclitaxel
-
Shanghai, Shanghai, ChinaHuashan Hospital Affiliated to Fudan University
Dec 8, 2022
Urothelial Carcinoma Bladder, Sperm Count, Low, Testis; Fibrosis Trial (Bacillus Calmette Guerin)
Not yet recruiting
- Urothelial Carcinoma Bladder
- +2 more
- Bacillus Calmette Guerin
- (no location specified)
Jan 18, 2023
Pancreatic Cancer Trial in Boston, Philadelphia (Gemcitabine, Nab-paclitaxel, Paricalcitol)
Active, not recruiting
- Pancreatic Cancer
- Gemcitabine
- +3 more
-
Boston, Massachusetts
- +1 more
Jan 9, 2023
Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)
Not yet recruiting
- Malignant Pleural Mesothelioma
- Gemcitabine
- supportive care
-
Cairo, EgyptAin Shams University Hospital
Dec 20, 2022
Resectable Pancreatic Cancer, Ductal Adenocarcinoma of the Pancreas Trial in Ulm (perioperative nab-paclitaxel/gemcitabine,
Completed
- Resectable Pancreatic Cancer
- Ductal Adenocarcinoma of the Pancreas
- perioperative nab-paclitaxel/gemcitabine
- adjuvant nab-paclitaxel/gemcitabine
-
Ulm, GermanyUniversity of Ulm, Dept. of Internal Medicine I
Nov 21, 2022
Pancreatic Cancer Trial in United States (Gemcitabine and Capecitabine)
Recruiting
- Pancreatic Cancer
- Gemcitabine and Capecitabine
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Dec 31, 2022
Pancreatic Tumors Trial in Shanghai (Sofantinib?abraxane?gemcitabine, Abraxane combined with gemcitabine)
Not yet recruiting
- Pancreatic Neoplasms
- Sofantinib、abraxane、gemcitabine
- Abraxane combined with gemcitabine
-
Shanghai, ChinaFudan University ShangHai Cancer Center
Jul 31, 2023
Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)
Active, not recruiting
- Malignant Pleural Mesothelioma
- Mesothelioma
- Cisplatin
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 5, 2023
Radical Cystectomy, Urothelial Carcinoma Trial in Wuhan (Disitamab Vedotin and Gemcitabine)
Recruiting
- Radical Cystectomy
- Urothelial Carcinoma
- Disitamab Vedotin and Gemcitabine
-
Wuhan, Hubei, China
- +1 more
Feb 9, 2023
Soft Tissue Sarcoma Trial in Winston-Salem (drug, radiation, procedure, other)
Recruiting
- Soft Tissue Sarcoma
- Gemcitabine
- +4 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Jan 26, 2023
Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,
Not yet recruiting
- Pancreatic Cancer, Stage IB
- +3 more
- sintilimab
- +2 more
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Jan 4, 2023
Gallbladder Cancer, Initially Unresectable, the First Line Treatment Trial in Shanghai (Combination of Gemcitabine,
Recruiting
- Gallbladder Cancer
- +2 more
- Combination of Gemcitabine, Nab-paclitaxel, Sintilimab and Bevacizumab
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 24, 2023
Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer Trial (Nab paclitaxel, Gemcitabine, NovoTTF-200T)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Resectable Pancreatic Cancer
- Nab paclitaxel
- +2 more
- (no location specified)
Dec 5, 2022
Peritoneal Carcinomatosis, Pancreas Tumor Trial in Rome (Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy
Recruiting
- Peritoneal Carcinomatosis
- Pancreas Neoplasm
- Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 11, 2023